These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11266917)

  • 1. Relevance of posttransplant HLA class I and class II antibodies on renal graft outcome.
    Piazza A; Poggi E; Borrelli L; Valeri M; Buonomo O; Servetti S; Adorno D; Casciani CU
    Transplant Proc; 2001; 33(1-2):478-80. PubMed ID: 11266917
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An association between posttransplant antibody production and renal transplant rejection.
    Worthington JE; Martin S; Dyer PA; Johnson RW
    Transplant Proc; 2001; 33(1-2):475-6. PubMed ID: 11266915
    [No Abstract]   [Full Text] [Related]  

  • 5. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving screening strategies for HLA-specific antibody detection in renal transplant recipients.
    Piazza A; Poggi E; Borrelli L; Monaco PI; Ozzella G; Cortini C; Torlone N; Servetti S; Casciani CU; Adorno D
    Transplant Proc; 2001; 33(1-2):391-2. PubMed ID: 11266877
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation.
    Díaz Varela I; Sánchez Mozo P; Centeno Cortés A; Alonso Blanco C; Valdés Cañedo F
    J Am Soc Nephrol; 2003 Oct; 14(10):2677-83. PubMed ID: 14514748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant immune monitoring of anti-HLA antibody.
    Kerman RH; Katz SM; Van Buren CT; Ruth J; McKissick E; Rasmussen S; Kahan BD
    Transplant Proc; 2001; 33(1-2):402. PubMed ID: 11266882
    [No Abstract]   [Full Text] [Related]  

  • 9. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
    Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
    Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class II DP epitopes.
    Deng CT; Cai J; Ozawa M; El-Awar N
    Clin Transpl; 2007; ():195-202. PubMed ID: 18637470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not.
    Roelen DL; van Bree J; Witvliet MD; Habraken I; van Beelen E; van't Sant PH; de Waal LP; van Rood JJ; Claas FH
    Transplantation; 1994 May; 57(9):1388-92. PubMed ID: 8184480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reactivity toward HLA class II determinants in renal transplantation.
    Iniotaki-Theodoraki A; Douramani P; Boletis J; Papassavas A; Theodoropoulou H; Kostakis A; Stavropoulos-Giokas C
    Transplant Proc; 2001; 33(1-2):461-4. PubMed ID: 11266910
    [No Abstract]   [Full Text] [Related]  

  • 18. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.
    Rodey GE; Neylan JF; Whelchel JD; Revels KW; Bray RA
    Hum Immunol; 1994 Apr; 39(4):272-80. PubMed ID: 7520897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.